Three-dimensional (3D) spheroid culture has applications in many fields as spheroids closely recapitulate physiological conditions. However, spheroid culture and maintenance are time-consuming and unsuitable for urgent situations; therefore, appropriate cryopreservation methods for spheroids are required for their use in an on-demand and ready-to-use manner. We hypothesized that the feasibility of a ready-to-use system relies on diffusion of the preservation solution within spheroids; we thus evaluated the effects of spheroid-forming parameters, such as cell number and culture period, on spheroid viability and functionality. Long-term spheroid culture for seven days interfered with penetration of the cryopreservation solution as it caused cell condensation and extracellular matrix (ECM) secretion, as well as low viability and migratory activity upon replating after storage. However, ready-to-use spheroids, which were cultured for one day and then cryopreserved, showed viability and migration similar to those of non-cryopreserved spheroids, confirming that a short incubation period was suitable for this system. The chondrocyte-based ready-to-use spheroid system designed in this study can be easily applied to regenerative medicine applications that require a large number of cells in the future and can provide information for applying the ready-to-use spheroid system to various cell types.

3D Spheroid Culture Chondrocytes Cryopreservation Ready-to-use System

Chaicharoenaudomrung N, Kunhorm P, Noisa P, World J. Stem Cells, 11, 1065 (2019)
Kang SW, Park JHO, Kim BS, J. Microbiol. Biotechnol., 15, 259 (2005)
Cho MO, Li Z, Shim HE, Cho IS, Nurunnabi M, Park H, Lee KY, Moon SH, Kim KS, Kang SW, Huh KM, NPG Asia Mater., 8, e309 (2016)
Moon SH, Kang SW, Park SJ, Bae D, Kim SJ, Lee HA, Kim KS, Hong KS, Kim JS, Do JT, Byun KH, Chung HM, Biomaterials, 34, 4013 (2013)
Kim W, Gwon Y, Park S, Kim H, Kim J, Bioact Mater, 19, 50 (2022)
Kim DE, Lee YB, Shim HE, Song JJ, Han JS, Moon KS, Huh KM, Kang SW, ACS Omega, 7, 18471 (2022)
Wang A, Madden LA, Paunov VN, J. Mater. Chem. B, 8, 10487 (2020)
Meneghel J, Kilbride P, Morris GJ, Front Med, 7, 592242 (2020)
Park Y, Huh KM, Kang SW, Int. J. Mol. Sci., 22, 2491 (2021)
Dong H, Li X, Chen K, Li N, Kagami H, Tissue Eng. Part C Methods, 27, 253 (2021)
Arai K, Murata D, Takao S, Verissiomo AR, Nakayama K, PLoS One, 15, e0230428 (2020)
Hunt CJ, Transfusion Med. Hemother., 46, 134 (2019)
Chang T, Zhao G, Adv. Sci., 8, 2002425 (2021)
Liu Y, Shah KM, Luo J, Front. Bioeng. Biotechnol., 9, 770655 (2021)
Lv Z, Li J, Xu X, Jiang Q, Shi D, Ann. Joint, 5, 33 (2020)
Lee JI, Sato M, Kim HW, Mochida J, Eur. Cell Mater, 22, 275 (2011)
Schulze-Tanzil G, Ann. Anat, 191, 325 (2009)
Jeon JH, Yun BG, Lim MJ, Kim SJ, Lim MH, Lim JY, Park SH, Kim SW, Tissue Eng. Regen Med., 17, 81 (2020)
Kang SW, Yoo SP, Kim BS, Biomed Mater. Eng., 17, 269 (2007)
Yhee JY, Kim YJ, Ryu JH, Yoon HY, Chang H, Park JH, Lee H, Jang HS, Jeong U, Kim K, Kang SW, Macromol. Biosci., 15, 1224 (2015)
Takahashi T, Ogasawara T, Asawa Y, Mori Y, Uchinuma E, Takato T, Hoshi K, Tissue Eng., 13, 1583 (2007)
Edmondson R, Broglie JJ, Adcock AF, Yang L, Assay Drug Dev. Technol., 12, 207 (2014)
Lin Z, Willers C, Xu J, Zheng MH, Tissue Eng., 12, 1971 (2006)
Jang TH, Park SC, Yang JH, Kim JY, Seok JH, Park US, Choi CW, Lee SR, Han J, Integr. Med. Res., 6, 12 (2017)
Pinto B, Henriques AC, Silva PMA, Bousbaa H, Pharmaceutics, 12, 1186 (2020)
Thakuri PS, Gupta M, Plaster M, Tavana H, Assay Drug Dev. Technol., 17, 140 (2019)
Ryu NE, Lee SH, Park H, Cells, 8, 1620 (2019)
Lee NH, Bayaraa O, Zechu Z, Kim HS, BMB Rep., 54, 356 (2021)